Prognostic relevance of HER2 expression and gene amplification in estrogen receptor-positive lymph-node negative breast cancer patients

被引：0
|
作者：
Peiro, G. [1 ]
Adrover, E. [1 ]
Aranda, F. [1 ]
Alenda, C. [1 ]
Peiro, F. [1 ]
Segui, J. [1 ]
机构：
[1] Univ Alacant, Gen Hosp, Dept Pathol, Alicante, Spain
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [21] Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
    Burstein, Harold J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1176 - 1177
  • [22] Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer
    Breaux, Andrea
    Turner, Bradley
    Wu, Xiaoyong
    Rai, Shesh N.
    Riley, Elizabeth C.
    Mandadi, Mounika
    Sanders, Mary Ann
    CLINICAL BREAST CANCER, 2019, 19 (01) : E261 - E269
  • [23] Prognostic role of HER2 expression in patients with estrogen receptor positive/HER2-negative breast cancer. Results from a populationbased cancer registry study
    Tommasi, C.
    Coriano, M.
    Serra, O.
    Pellegrino, B.
    Zanoni, D.
    Faccini, F.
    Michiara, M.
    Sgargi, P.
    Giuliano, C.
    Ferretti, S.
    Grossi, V.
    Ravaioli, A.
    Zamagni, F.
    Falcini, F.
    Musolino, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 37 - 37
  • [24] Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
    Burstein, Harold J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (26): : 2557 - 2570
  • [25] EXTRACAPSULAR EXTENSION OF AXILLARY LYMPH NODE METASTASES IN HER2 RECEPTOR POSITIVE AND NEGATIVE BREAST CANCERS: PROGNOSTIC VALUE
    Maksimovic, S.
    ANNALS OF ONCOLOGY, 2009, 20 : 28 - 28
  • [26] Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis
    Srour, Marissa K.
    Qu, Ying
    Deng, Nan
    Carlson, Kjirsten
    Mirocha, James
    Gao, Bowen
    Dadmanesh, Farnaz
    Cui, Xiaojiang
    Giuliano, Armando E.
    BREAST JOURNAL, 2021, 27 (05): : 432 - 440
  • [27] MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer
    Choschzick, Matthias
    Heilenkoetter, Uwe
    Lebeau, Annette
    Jaenicke, Fritz
    Terracciano, Luigi
    Bokemeyer, Carsten
    Sauter, Guido
    Simon, Ronald
    CANCER BIOMARKERS, 2010, 8 (02) : 53 - 60
  • [28] Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
    Iwamoto, Takayuki
    Kelly, Catherine
    Mizoo, Taeko
    Nogami, Tomohiro
    Motoki, Takayuki
    Shien, Tadahiko
    Taira, Naruto
    Hayashi, Naoki
    Niikura, Naoki
    Fujiwara, Toshiyoshi
    Doihara, Hiroyoshi
    Matsuoka, Junji
    CLINICAL BREAST CANCER, 2016, 16 (02) : 95 - 100
  • [29] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Wu, Lunpo
    Wang, Qinghua
    Zhou, Shishi
    Tang, Wanfen
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Hong, Zhongwu
    Fu, Jianfei
    Du, Jinlin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1145 - 1153
  • [30] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Hongjuan Zheng
    Chenyang Ge
    Haiping Lin
    Lunpo Wu
    Qinghua Wang
    Shishi Zhou
    Wanfen Tang
    Xia Zhang
    Xiayun Jin
    Xifeng Xu
    Zhongwu Hong
    Jianfei Fu
    Jinlin Du
    International Journal of Clinical Oncology, 2022, 27 : 1145 - 1153
12345